research

4 July 2025

Researchers at the IIS Aragón have identified a new therapeutic target to prevent metastasis in pancreatic cancer.

The "Metabolism and Tumor Stem Cells" group at the IIS Aragón has demonstrated a novel way to slow the progression and metastasis of this type of cancer in animal models.
30 June, 2025

A new non-invasive technology allows access to the brain through the muscles

Jaime Ibáñez, a researcher at the Aragón Engineering Research Institute (I3A) and the IIS Aragón, leads this line of work to turn muscles into a window into the activity of the central nervous system by taking advantage of advances in muscle sensors and artificial intelligence.
18 June, 2025

The IIS Aragón and the Ibercaja Foundation have signed an agreement to promote the innovative oncology research project "Sara."

This research, led by the Molecular Oncology Group at the IIS Aragón, aims to improve the efficacy of chemotherapy while significantly reducing its adverse effects. The signing of this agreement reinforces the commitment of both institutions to the advancement of cancer research in Aragon.
3 June, 2025

The IIS Aragón and the association TheMoveMen sign an agreement to promote research into male cancer.

This new agreement will allow for the development of joint projects in research, outreach, and training on male cancer, strengthening the connection between science and society. This collaboration was born out of the annual grant TheMoveMen awarded last November to the "Virtual Biopsy" project, led by ARAID researcher Alberto J. Schuhmacher of the IIS Aragón.
10 April 2025

A special T-shirt after breast cancer surgery

Surgeons from Servet, together with the AECC in Zaragoza and Amac Gema, have designed a garment for patients leaving the hospital with drains. This initiative will be presented today at the 4th Aragonese Breast Cancer Humanization Conference, organized by the IIS Aragón in the Patio de la Infanta.
7 April 2025

Interview with Alberto J. Schuhmacher: "I don't like the war on cancer being talked about outside the laboratory."

Today, Aragón interviews Alberto Jiménez Schuhmacher, Principal Investigator of the Molecular Oncology Group at the IIS Aragón, where he is developing a cancer diagnostic technique known as "virtual biopsy" and another fluorescence-guided surgery technique. His goal is to achieve more efficient and less invasive diagnosis of the most lethal brain tumors, pancreatic cancer, and certain childhood tumors.